AML
2 competing products in clinical development for AML.
Pipeline by Phase
Pre-clinical1
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Quizartinib + Salvage Chemotherapy | Daiichi Sankyo | Phase 3 | Completed | 40 |
| ASP2215 | Astellas Pharma | Pre-clinical | Completed | 26 |